Skip to content
Search

Latest Stories

Gisela Abbam reappointed as GPhC Chair

Gisela took on the role of GPhC chair in 2022

Gisela Abbam reappointed as GPhC chair

Gisela Abbam

Gisela Abbam has been reappointed as Chair of the General Pharmaceutical Council (GPhC) for a second term.

Previously, Gisela was Chair of the British Science Association (BSA). She took on the role of GPhC chair on 14 March 2022.


The Privy Council confirmed her reappointment, extending her tenure from 1 April 2025 until the end of March 2029.

Commenting on her reappointment, Gisela said: “I am delighted to be reappointed as chair and to continue to lead the important work being carried out at the GPhC.

“I understand that there are significant ongoing challenges for pharmacy and we will continue the listening exercise to provide whatever support we can.”

Gisela acknowledged that patients and their carers have been affected by medicines shortages, while pharmacy teams are grappling with workplace and financial pressures, impacting overall well-being.

She expressed appreciation for those working in pharmacy who are supporting their communities and helping people with their health needs while reaffirming the GPhC’s commitment to use all of its regulatory levers and influence to make a positive difference.

“Major reforms to health and social care are currently being discussed across England, Scotland and Wales.

“I aim to make sure pharmacy and pharmacy regulation is at the heart of those discussions, to ensure patients and the public get safe and effective care and have confidence in pharmacy now and in the future,” she added.

Elizabeth Mailey, a pharmacist member of Council, who was involved in the reappointment process, shared that Gisela has effectively led the Council to help drive forward their aims in her first term and has brought a real focus on “how the GPhC can support pharmacy, and the whole pharmacy team, to deliver improved care for patients and the public.”

“I am delighted that Gisela has been reappointed for a second term, so Gisela can continue to provide clear leadership as the GPhC finalises and implements its strategy for the next five years,” she said.

More For You

RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less